References
- Adam, R.C., Yang, H., Rockowitz, S., Larsen, S.B., Nikolova, M., Oristian, D.S., Polak, L., Kadaja, M., Asare, A., Zheng, D., et al. (2015). Pioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice. Nature 521, 366-370. https://doi.org/10.1038/nature14289
- Bee, T., Swiers, G., Muroi, S., Pozner, A., Nottingham, W., Santos, A.C., Li, P.S., Taniuchi, I., and de Bruijn, M.F. (2010). Nonredundant roles for Runx1 alternative promoters reflect their activity at discrete stages of developmental hematopoiesis. Blood 115, 3042-3050. https://doi.org/10.1182/blood-2009-08-238626
- Blyth, K., Cameron, E.R., and Neil, J.C. (2005). The RUNX genes: gain or loss of function in cancer. Nat. Rev. Cancer 5, 376-387. https://doi.org/10.1038/nrc1607
- Burns, C.E., Traver, D., Mayhall, E., Shepard, J.L., and Zon, L.I. (2005). Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 19, 2331-2342. https://doi.org/10.1101/gad.1337005
- Choi, E., Hendley, A.M., Bailey, J.M., Leach, S.D., and Goldenring, J.R. (2016). Expression of activated Ras in gastric chief cells of mice leads to the full spectrum of metaplastic lineage transitions. Gastroenterology 150, 918-930.e13. https://doi.org/10.1053/j.gastro.2015.11.049
- de Bruijn, M. and Dzierzak, E. (2017). Runx transcription factors in the development and function of the definitive hematopoietic system. Blood 129, 2061-2069. https://doi.org/10.1182/blood-2016-12-689109
- Ghozi, M.C., Bernstein, Y., Negreanu, V., Levanon, D., and Groner, Y. (1996). Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc. Natl. Acad. Sci. U. S. A. 93, 1935-1940. https://doi.org/10.1073/pnas.93.5.1935
- Growney, J.D., Shigematsu, H., Li, Z., Lee, B.H., Adelsperger, J., Rowan, R., Curley, D.P., Kutok, J.L., Akashi, K., Williams, I.R., et al. (2005). Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 106, 494-504.
- Ichikawa, M., Asai, T., Saito, T., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Ogawa, S., Kurokawa, M., et al. (2004). AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat. Med. 10, 299-304. https://doi.org/10.1038/nm997
- Ito, Y., Bae, S.C., and Chuang, L.S. (2015). The RUNX family: developmental regulators in cancer. Nat. Rev. Cancer 15, 81-95. https://doi.org/10.1038/nrc3877
- Komeno, Y., Yan, M., Matsuura, S., Lam, K., Lo, M.C., Huang, Y.J., Tenen, D.G., Downing, J.R., and Zhang, D.E. (2014). Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice. Blood 123, 3760-3769. https://doi.org/10.1182/blood-2013-08-521252
- Kwiatkowski, N., Zhang, T., Rahl, P.B., Abraham, B.J., Reddy, J., Ficarro, S.B., Dastur, A., Amzallag, A., Ramaswamy, S., Tesar, B., et al. (2014). Targeting transcription regulation in cancer with a covalent CDK7 inhibitor. Nature 511, 616-620. https://doi.org/10.1038/nature13393
- Leushacke, M., Tan, S.H., Wong, A., Swathi, Y., Hajamohideen, A., Tan, L.T., Goh, J., Wong, E., Denil, S., Murakami, K., et al. (2017). Lgr5-expressing chief cells drive epithelial regeneration and cancer in the oxyntic stomach. Nat. Cell Biol. 19, 774-786. https://doi.org/10.1038/ncb3541
- Liau, W.S., Ngoc, P.C., and Sanda, T. (2017). Roles of the RUNX1 enhancer in normal hematopoiesis and leukemogenesis. Adv. Exp. Med. Biol. 962, 139-147. https://doi.org/10.1007/978-981-10-3233-2_10
- Lichtinger, M., Ingram, R., Hannah, R., Muller, D., Clarke, D., Assi, S.A., Lie, A.L.M., Noailles, L., Vijayabaskar, M.S., Wu, M., et al. (2012). RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. EMBO J. 31, 4318-4333. https://doi.org/10.1038/emboj.2012.275
- Matsuo, J., Kimura, S., Yamamura, A., Koh, C.P., Hossain, M.Z., Heng, D.L., Kohu, K., Voon, D.C., Hiai, H., Unno, M., et al. (2017). Identification of stem cells in the epithelium of the stomach corpus and antrum of mice. Gastroenterology 152, 218-231.e14. https://doi.org/10.1053/j.gastro.2016.09.018
- Mitsuda, Y., Morita, K., Kashiwazaki, G., Taniguchi, J., Bando, T., Obara, M., Hirata, M., Kataoka, T.R., Muto, M., Kaneda, Y., et al. (2018). RUNX1 positively regulates the ErbB2/HER2 signaling pathway through modulating SOS1 expression in gastric cancer cells. Sci. Rep. 8, 6423. https://doi.org/10.1038/s41598-018-24969-w
- Miyoshi, H., Shimizu, K., Kozu, T., Maseki, N., Kaneko, Y., and Ohki, M. (1991). t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc. Natl. Acad. Sci. U. S. A. 88, 10431-10434. https://doi.org/10.1073/pnas.88.23.10431
- Ng, C.E., Yokomizo, T., Yamashita, N., Cirovic, B., Jin, H., Wen, Z., Ito, Y., and Osato, M. (2010). A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells. Stem Cells 28, 1869-1881. https://doi.org/10.1002/stem.507
- Nottingham, W.T., Jarratt, A., Burgess, M., Speck, C.L., Cheng, J.F., Prabhakar, S., Rubin, E.M., Li, P.S., Sloane-Stanley, J., Kong, A.S.J., et al. (2007). Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata/Ets/SCL-regulated enhancer. Blood 110, 4188-4197. https://doi.org/10.1182/blood.v110.11.4188.4188
- Osato, M. (2004). Point mutations in the RUNX1/AML1 gene: another actor in RUNX leukemia. Oncogene 23, 4284-4296. https://doi.org/10.1038/sj.onc.1207779
- Osorio, K.M., Lee, S.E., McDermitt, D.J., Waghmare, S.K., Zhang, Y.V., Woo, H.N., and Tumbar, T. (2008). Runx1 modulates developmental, but not injury-driven, hair follicle stem cell activation. Development 135, 1059-1068. https://doi.org/10.1242/dev.012799
- Sanda, T., Lawton, L.N., Barrasa, M.I., Fan, Z.P., Kohlhammer, H., Gutierrez, A., Ma, W., Tatarek, J., Ahn, Y., Kelliher, M.A., et al. (2012). Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 22, 209-221. https://doi.org/10.1016/j.ccr.2012.06.007
- Scheitz, C.J., Lee, T.S., McDermitt, D.J., and Tumbar, T. (2012). Defining a tissue stem cell-driven Runx1/Stat3 signalling axis in epithelial cancer. EMBO J. 31, 4124-4139. https://doi.org/10.1038/emboj.2012.270
- Sood, R., Kamikubo, Y., and Liu, P. (2017). Role of RUNX1 in hematological malignancies. Blood 129, 2070-2082. https://doi.org/10.1182/blood-2016-10-687830
- Sroczynska, P., Lancrin, C., Kouskoff, V., and Lacaud, G. (2009). The differential activities of Runx1 promoters define milestones during embryonic hematopoiesis. Blood 114, 5279-5289. https://doi.org/10.1182/blood-2009-05-222307
- Sugimura, R., Jha, D.K., Han, A., Soria-Valles, C., da Rocha, E.L., Lu, Y.F., Goettel, J.A., Serrao, E., Rowe, R.G., Malleshaiah, M., et al. (2017). Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature 545, 432-438. https://doi.org/10.1038/nature22370
- Sun, W. and Downing, J.R. (2004). Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. Blood 104, 3565-3572.
- Uenishi, G.I., Jung, H.S., Kumar, A., Park, M.A., Hadland, B.K., McLeod, E., Raymond, M., Moskvin, O., Zimmerman, C.E., Theisen, D.J., et al. (2018). NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells. Nat. Commun. 9, 1828. https://doi.org/10.1038/s41467-018-04134-7
- Usui, T., Aoyagi, K., Saeki, N., Nakanishi, Y., Kanai, Y., Ohki, M., Ogawa, K., Yoshida, T., and Sasaki, H. (2006). Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells. Int. J. Oncol. 29, 779-784.
- Whyte, W.A., Orlando, D.A., Hnisz, D., Abraham, B.J., Lin, C.Y., Kagey, M.H., Rahl, P.B., Lee, T.I., and Young, R.A. (2013). Master transcription factors and mediator establish super-enhancers at key cell identity genes. Cell 153, 307-319. https://doi.org/10.1016/j.cell.2013.03.035
- Zaret, K.S. and Carroll, J.S. (2011). Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227-2241. https://doi.org/10.1101/gad.176826.111